PlainRecalls
FDA Devices Moderate Class II Ongoing

RX Series Copper (Cu) Assay Ref. Number CU2340

Reported: February 14, 2024 Initiated: November 29, 2023 #Z-0992-2024

Product Description

RX Series Copper (Cu) Assay Ref. Number CU2340

Reason for Recall

Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.

Details

Recalling Firm
Randox Laboratories Ltd.
Units Affected
3,053 kits (2 US, 3,051 OUS)
Distribution
US Nationwide distribution in the states of SC and OK.
Location
Crumlin (North)

Frequently Asked Questions

What product was recalled?
RX Series Copper (Cu) Assay Ref. Number CU2340. Recalled by Randox Laboratories Ltd.. Units affected: 3,053 kits (2 US, 3,051 OUS).
Why was this product recalled?
Randox Laboratories have released an update to the Carryover Avoidance Technical Bulletin to detail that Copper, should not be run directly after Total Protein, on the RX series instruments testing order. If copper assay is run after total protein it could lead to falsely elevated copper results.
Which agency issued this recall?
This recall was issued by the FDA Devices on February 14, 2024. Severity: Moderate. Recall number: Z-0992-2024.